Clinical experience with sonographic contrast agents

Seminars in Ultrasound CT and MRI

Volumn 18, Issue 1, 1997, Pages 3-12

  Melany, Michelle L ^a   Grant, Edward G ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; KIDNEY ARTERY STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; ULTRASOUND;

EID: 0030996904     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(97)90033-0     Document Type: Review

References (40)

1. Schlief R, Deichert, U: Hysterosalpingo-contrast sonography of the uterus and fallopian tubes: Results of a clinical trial of a new contrast medium in 120 patients. Radiology 178:213-215, 1991
2. Dietrich M, Suren A, Hinney B, et al: Evaluation of tuba patency by hysterocontrast sonography (HyCoSy, Echovist) and its correlation with laparoscopic findings. J Clin Ultrasound 24:523-527, 1996
3. Parker KJ, Tuthill TA, Lerner RM, et al: A particulate contrast agent with potential for ultrasound imaging of the liver. Ultrasound Med Biol 13:555-566, 1987
4. Mattrey RF, Scheible FW, Gosink BB, et al: Perfluoroctylbromide: A liver/spleen-specific and tumor imaging ultrasound contrast material. Radiology 145:759-762, 1982
5. Mattrey RF, Strich G, Shelton RE, et al: Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: Preliminary clinical results. Radiology 163:339-343, 1987
6. Behan M, O'Connell D, Mattrey R, et al: Perfluoroctylbromide as a contrast agent for CT and sonography: Preliminary clinical results. Am J Roentgenol 160:399-405, 1993
7. Forsberg F, Liu JB, Merton DA, et al: Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 14:949-957, 1995
8. Matsuda Y, Yabuuchi T: Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 161:701-705, 1986
9. Kudo M, Tomita S, Tochio J: Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): Value in differential diagnosis of hepatic tumors. Am J Roentgenol 158:65-74, 1992
10. Bleeker H, Shun K, Barnhart J: Ultrasonic characterization of Albunex, a new contrast agent. J Acoust Soc Am 12:322-324, 1990
11. Wilson S, Burns PN: Microbubble destruction is the origin of harmonic signals from FSO69. Presented at Radiologic Society of North America, 1996, Chicago IL.
12. Goldberg BB: Ultrasound contrast agents, in Wells PNT, (ed): Advances in Ultrasound Techniques and Instrumentation. New York, NY, Churchill Livingstone, 1993, pp 35-46
13. Newhouse V, Hoover M, Ash S: The detection of blood impurities using ultrasound Doppler. Ultrason Imaging 2:370-380, 1980
14. Goldberg BB, Liu JB, Forsberg F: Ultrasound contrast agents: A review. Ultrasound Med Biol 20:319-333, 1994
15. Ophir J, Parker KJ: Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15:353-356, 1989
16. Fan P, Czuwala P, Nanda N, et al: Comparison of various agents in contrast enhancement of color Doppler flow images: An in-vitro study. Ultrasound Med Biol 19:45-57, 1993
17. Forsberg F, Liu JB, Burns PN, et al: Artifacts in ultrasound contrast agent studies. J Ultrasound Med 13:357-365, 1994
18. Burns PN: Harmonic imaging with ultrasound contrast agents. Clin Radiol 51:50-55, 1996
19. Needleman L, Forsberg F: Contrast agents in ultrasound. Ultrasound Quarterly 13:121-138, 1996
20. Burns PN, Powers, JE, Hope-Simpson D, et al: Power Doppler imaging combined with contrast enhancing harmonic Doppler: New method for small vessel imaging. Radiology 193:(S)366, 1994 (suppl, abstr)
21. Hilpert PL, Mattrey RF, Mitten RM, et al: IV injection of air-filled human microspheres to enhance arterial Doppler signal: A preliminary study in rabbits. Am J Roentgenol 153:613-616, 1989
22. Smith MD, Elion JL, McClure RR, et al: Left heart opacification with peripheral venous injection of a new saccharide echo-contrast agent in dogs. J Am Coll Cardiol 13:1622-1626, 1989
23. Fritzsch TH, Schartl M, Siegert J: Pre-clinical and clinical results with an ultrasonic contrast agent. Invest Radiol 23:(S)302, 1988 (suppl, abstr)
24. Unger EC, Lund PJ, Shen DK, et al: Nitrogen filled liposomes as a vascular US contrast agent: Preliminary evaluation. Radiology 185:453-456, 1992
25. Fink IJ, Miller DJ, Shawker TH: Lipid emulsions as contrast agents for hepatic sonography: An experimental study in rabbits. Ultrasound Imaging 7:191-194, 1985
26. Quay SC: Ultrasound contrast agent development: Phase shift colloids. J Ultrasound Med 13:(S)9, 1994 (suppl, abstr)
27. Crouse L, Cheirif J, Hanly D, et al: Opacification and border delineation improvement in patients with suboptimal endocardia! border definition in routine echocardiography; results of a phase III Albunex multicenter trial. J Am Coll Cardiol 22:1494-1500, 1993
28. Harmon B, Grant EG, Wiegel B, et al: An open label study to assess the safety and efficacy of Albunex in lower extremity Doppler in patients with suspected deep venous thrombosis in the lower extremities. Presented at the American Roentgen Ray Society Meeting, April 30-May 5, 1995, Washington, DC
29. Needleman L, Nack TL, Feld RI, et al: Initial experience with an US contrast agent in upper-extremity venous thrombosis. Radiology 185:(S)143, 1992 (suppl, abstr)
30. Vorwerk D, Gehl H, Nelles A, et al: Dynamic contrast medium-aided ultrasound venacavography in patients with caval filters. Ultraschall Med 11:146-149, 1990
31. Schlief R: Galactose based echo-enhancing agents. Proceedings of the symposium on ultrasound contrast agents. The leading edge in diagnostic ultrasound, Atlantic City, NJ, 1995, 25-26
32. Needleman L, Goldberg BB, Feld RI, et al: Evaluation of arterial disease in humans using an ultrasound contrast agent. J Ultrasound Med 14:(S)48, 1995 (suppl, abstr)
33. Schwartz K, Becher H, Schimpfky C, et al: Doppler enhancement with SHU508A in multiple vascular regions. Radiology 193:195-201, 1994
34. Balen F, Allen C, Lees W: Ultrasound contrast agents. Clin Radiol 49:77-82, 1994
35. Sitzer M, Furst G, Siebler M, et al: Usefulness of an intravenous contrast medium in the characterization of high grade internal carotid stenosis with color Doppler assisted duplex imaging. Stroke 25:385-389, 1994
36. Otis S, Rush M, Boyajian R: Contrast enhanced transcranial imaging. Results of an American phase two study. Stroke 26:203-209, 1995
37. Jauss M, Kaps M, Keberle M, et al: A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke 25:1265-1267, 1994
38. Kloetzsch C, Janssen G, Berlit P: Transesophageal echocardiography and contrast transcranial Doppler in the detection of patent foramen ovale: Experiences in 111 patients. Neurology 44:1603-1606, 1994
39. Schlief R, Schurmann R, Niendorf H: Blood pool enhancement with SHU508A: Results of phase II clinical trials. Invest Radiol 26:(S)188-189, 1991 (suppl)
40. Melany ML, Grant EG, Duerinckx AJ, et al: Initial experience with a phase shift ultrasound contrast agent (dodecafluoropentane) for imaging of the renal arteries. Presented at Radiological Society of North America. Chicago IL, December 3, 1996. Radiology (in press)